Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
19 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Neoclarityn“
Suchtreffer
Begriffe & Kennungen
Neoclarityn · 4.8 Undesirable effects · 2
Eintrag öffnenNeoclarityn · 4.8 · 11 System Organ Class Frequency Adverse reactions seen with Neoclarityn Metabolism and nutrition Not known Inc
Eintrag öffnenNeoclarityn · 4.8 · 12 Confidence Interval (CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new onset seizu
Eintrag öffnenNeoclarityn · 4.8 · 4 Confidence Interval (CI) 10.5-64.5) per 100,000 person years (PY) with a background rate of new onset seizur
Eintrag öffnenNeoclarityn · 4.8 · A retrospective observational safety study indicated an increased incidence of new-onset seizure in patients 0
Eintrag öffnenNeoclarityn · 4.8 · A retrospective observational safety study indicated an increased incidence of new-onset seizure in patients 0
Eintrag öffnenNeoclarityn · 4.8 · Adults and adolescents At the recommended dose, in clinical trials involving adults and adolescents in a range
Eintrag öffnenNeoclarityn · 4.8 · In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event wa
Eintrag öffnenNeoclarityn · 4.8 · In a clinical trial with 578 adolescent patients, 12 through 17 years of age, the most common adverse event wa
Eintrag öffnenNeoclarityn · 4.8 · In clinical trials in a paediatric population, the desloratadine syrup formulation was administered to a total
Eintrag öffnenNeoclarityn · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenNeoclarityn · 4.8 · Paediatric population Other undesirable effects reported during the post-marketing period in paediatric patien
Eintrag öffnenNeoclarityn · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenNeoclarityn · 4.8 · Reporting of suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medi
Eintrag öffnenNeoclarityn · 4.8 · Summary of the safety profile
Eintrag öffnenNeoclarityn · 4.8 · Summary of the safety profile In clinical trials in a range of indications including allergic rhinitis and chr
Eintrag öffnenNeoclarityn · 4.8 · System Organ Class Frequency Adverse reactions seen with Neoclarityn Metabolism and nutrition Not known Increa
Eintrag öffnenNeoclarityn · 4.8 · Tabulated list of adverse reactions The frequency of the clinical trial adverse reactions reported in excess o
Eintrag öffnenNeoclarityn · 4.8 · Tabulated list of adverse reactions The frequency of the clinical trial adverse reactions reported in excess o
Eintrag öffnen